Tower Research Capital (TRC)’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.7K | Buy |
17,606
+10,742
| +156% | +$24.8K | ﹤0.01% | 3142 |
|
|
2025
Q1 | $9.54K | Sell |
6,864
-44,221
| -87% | -$61.5K | ﹤0.01% | 3762 |
|
|
2024
Q4 | $88.4K | Buy |
51,085
+37,233
| +269% | +$64.4K | ﹤0.01% | 2210 |
|
|
2024
Q3 | $27.8K | Buy |
13,852
+815
| +6% | +$1.64K | ﹤0.01% | 3049 |
|
|
2024
Q2 | $29.2K | Sell |
13,037
-11,092
| -46% | -$24.8K | ﹤0.01% | 3504 |
|
|
2024
Q1 | $69.3K | Buy |
24,129
+21,258
| +740% | +$61K | ﹤0.01% | 2061 |
|
|
2023
Q4 | $5.08K | Buy |
+2,871
| New | +$5.08K | ﹤0.01% | 4883 |
|
|
2023
Q3 | – | Sell |
-14,435
| Closed | -$9.54K | – | 6217 |
|
|
2023
Q2 | $9.54K | Buy |
14,435
+7,180
| +99% | +$4.75K | ﹤0.01% | 4236 |
|
|
2023
Q1 | $6K | Sell |
7,255
-3,763
| -34% | -$3.11K | ﹤0.01% | 4885 |
|
|
2022
Q4 | $25K | Buy |
11,018
+1,655
| +18% | +$3.76K | ﹤0.01% | 2932 |
|
|
2022
Q3 | $18K | Buy |
9,363
+6,104
| +187% | +$11.7K | ﹤0.01% | 4028 |
|
|
2022
Q2 | $12K | Buy |
3,259
+1,659
| +104% | +$6.11K | ﹤0.01% | 4314 |
|
|
2022
Q1 | $10K | Buy |
1,600
+420
| +36% | +$2.63K | ﹤0.01% | 4352 |
|
|
2021
Q4 | $14K | Buy |
1,180
+390
| +49% | +$4.63K | ﹤0.01% | 4109 |
|
|
2021
Q3 | $15K | Sell |
790
-186
| -19% | -$3.53K | ﹤0.01% | 4000 |
|
|
2021
Q2 | $21K | Buy |
976
+350
| +56% | +$7.53K | ﹤0.01% | 3857 |
|
|
2021
Q1 | $13K | Buy |
626
+333
| +114% | +$6.92K | ﹤0.01% | 4226 |
|
|
2020
Q4 | $8K | Buy |
+293
| New | +$8K | ﹤0.01% | 4441 |
|